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I. Introduction 
Mammalian neurolathyrism is a progressive and 
degenerative disease of central nervous system ori- 
ginating from excessive consumption of Lafhyrus 
seeds, particularly those of L. sativus. Rao et al. [I] 
have isolated P-N-oxalyl-L-a&diaminopropionic 
acid (ODAP) from the seeds of L. satiuus and shown 
this substance to be the neurotoxin [ 1, 21 Charac- 
terization of the biochemical effect and cellular site 
of action of ODAP is required for clarifying the re- 
lation between chronic ingestion of this substance, 
its neurotoxicity, and degenerative ffects in the 
brain. 
ODAP is structurally analogous to glutamate. 
Since glutamate and ammonia metabolism are as- 
sociated with mitochondria, and because acute doses 
of ODAP led to ammonia toxicity in rats [3], an 
investigation of the action of ODAP on glutamate 
metabolism in isolated brain mitochondria was under- 
taken. 
The results presented in this communication 
show 
brain 
a) 
b) 
c) 
that ODAP affects the metabolism of isolated 
mitochondria through: 
an apparent inhibition of respiration with glu- 
tamate, glutamine or cY-ketoglutarate; 
inhibition of glutamate transport across the 
inner mitochondrial membrane; and by 
apparent activation of mitochondrial gluta- 
minase. 
* This paper is dedicated to the memory of Professor 
P.S. Sarma, Department of Biochemistry, Indian Institute 
of Science, Bangalore, India. 
2. Materials and methods 
Mitochondria were isolated from bovine brain 
following the centrifugation schedule of Stahl et al. 
[4] , and using the isolation medium of Moore and 
Jobsis [S] , Ficoll gradients were not utilized in our 
procedure; instead, mitochondria were washed once 
with 8% Ficoll solution in isolation medium. 
Protein was determined by a modification of the 
biuret method [6] using bovine serum albumin as 
a standard. 
Uptake of oxygen by brain mitochondria was de- 
termined polarographically at 26” in a 3 ml reaction 
mixture with the Clark oxygen electrode. The assay 
medium contained 225 mM mannitol, 75 mM sucrose, 
0.5 mM MgClz , 10 mM phosphate, 10 mM KCl, 5 mM 
Tris, 0.33 mM EDTA, 0.5 PM FCCP, 1 mg/ml bovine 
serum albumin, 4 mM substrate and 2-3 mg/ml mito- 
chondrial protein, at pH 7.4. 
The uptake of glutamate by brain mitochondria 
was followed by measuring volume changes by photo- 
metric means. The assay medium contained 225 mM 
mannitol, 75 mM sucrose, 1 mM phosphate, 10 mM 
KCl, 5 mM Tris, 0.33 mM EDTA at pH 7.4. Usually 
the final mitochondria concentration was 1 mg/ml. 
Assay of glutaminase I in mitochondria was 
carried out according to Meister [7]. Glutamic de- 
hydrogenase and glutamic-oxaloacetic aminotrans- 
ferase were estimated by the procedures of Strecker 
[8] and Karmen [9], respectively. 
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Table 1 MITOCHONDAIA 25 mM No GLUTAMATE 
Effect of ODAP on the rates of respiration of 
brain mitochondria. 
Oxygen consumption 
(natoms/min/mg protein) \ 1 mM No SUCCINATE 
Succinate 
o-Glycero- 
phosphate 
Glutamate 
Glutamine 
a-Ketoglutarate 
Control 
57.0 
48.0 
21.0 
18.0 
36.0 
+3mM Inhibition 
ODAP (%I 
60.0 _ 
48.0 _ 
9.0 57.1 
6.0 66.7 
24.0 33.4 
ROTENONE No GLUTAMATE , mM 
MITOCHONDRIA 
+ 
No SUCCINATE 
Brain mitochondria (2 mg/ml) in a basic respiration medium 
of 225 mM mannitol, 75 mM sucrose, 0.5 mM MgCla, 10 
mM phosphate, 10 mM KCl, 5 mM Tris, 0.33 mM EDTA, 
0.5 PM FCCP and 1 mg/ml bovine serum albumin, pH 7.4. 
Respiratory substrates were 4 mM. The results represent 
the average of 3 independent experiments. 
3. Results 
The effects of ODAP on the respiration of mito- 
chondria using succinate, a-glycerophosphate, gluta- 
mate, glutamine and cY-ketoglutarate are summarized 
in table 1. It is apparent that the respiratory rates 
decrease only when glutamate, glutamine or a-keto- 
glutarate are used as oxidizable substrates. The ex- 
tent of inhibition depends on the relative concentra- 
tion of glutamate and ODAP and the maximal effect 
is obtained when the ratio of the substrate to inhi- 
bitor is approx. 1:4. This behavior could arise either 
due to inhibition of the respiratory chain redox re- 
actions or reflects decreased uptake of glutamate 
across the mitochondrial membrane. 
Fig. 1. Effect of ODAP on glutamate-dependent swelling. 
Assay medium: 225 mM mannitol, 75 mM sucrose, 1 mM 
phosphate, 10 mM KCI, 5 mM Tris, 0.33 mM EDTA. pH 7.4. 
Bovine brain mitochondria 1 mg/ml. 
Also, approximate calculations suggest hat neuro- 
lathyrism would occur only when ingestion of L. 
sativus seeds leads to 5-10 mM circulating ODAP. 
Hence, it is possible that apart from its effect on glu- 
tamate transport, ODAP might also influence other 
reactions in glutamate metabolism, e.g., those cata- 
lyzed by glutaminase I, glutamic dehydrogenase or 
aminotransferases. Indeed, this has been confirmed 
qualitatively, but the most striking effect is the ap- 
parent stimulation of glutaminase activity (table 2). 
Accordingly, to distinguish between these alter- 
natives, the effect of ODAP on glutamate uptake was 
studied as a function of mitochondrial volume 
changes. The experiments were carried out in the 
presence of rotenone which blocks the oxidation of 
glutamate. The energy required for glutamate trans- 
port was derived through rotenone insensitive oxi- 
dation of succinate. The results presented in fig. 1 
clearly demonstrate that ODAP inhibits glutamate 
dependent swelling. Fig. 2 shows that ODAP exerts 
its effects through fully competitive binding-pre- 
sumably to the glutamate carrier present in the mito 
chondrial membrane. 
4. Discussion 
In isolated brain mitochondria, ODAP at high con- 
centration inhibits glutamate transport and several 
metabolic pathways; but stimulates glutamate and 
ammonia formation by an apparent activation of 
glutaminase. Cheema et al. [IO] have reported that 
ODAP administration to young rats increases the 
activity of a soluble glutaminase enzyme and that 
ODAP has no effect on glutamine synthetase and 
slightly inhibits glutamic dehydrogenase. 
Our findings suggest hat ammonia toxicity in the 
transmittance 
ODAP 
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Table 2 
Stimulation of glutaminase activity. 
Mitochondria 
(ml) 
Substrate 
(2X 10-3M) 
ODAP 
(M) 
nmoles NH3/ 
min/mg protein 
0.05 
_ 
- 
0.05 
0.05 
0.05 
0.05 
Glutamine _ 196.0 
Glu tamine _ 8.0 
Glutamine 5x104 9.2 
_ 2x 1o-3 0.0 
_ _ 0.0 
Glutamine 1x10’ 265.0 
Glutamine 5x10” 341 .o 
Glutamine 2 x 1o-3 471.0 
The glutaminase incubation system contained in a total volume of 1 ml: 20 pmoles glutamine; 20 pmoles phosphate buffer 
pH 7.8; 0.15 mg protein. Incubation at 37” for 10 min. The results are averaged over 6 independent assays. 
1.8 , [ I I 
t2 mM ODAP/ 
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Fig. 2. Competitive inhibition by ODAP of the glutamate- 
dependent swelling. Experimental conditions as given in fig. 1. 
brain could arise after prolonged treatment of an 
animal with ODAP by combined activation of glu- 
taminase and inhibition of glutamate transport and 
oxidation. A resulting ammonia accumulation could 
activate lysosomal hydrolases, consequently causing 
brain damage. Activation of brain lysosomes has 
recently been observed by Lakskamanan et al. [ 1 I] 
following acute administration of ODAP. 
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